Response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol: 38 cases (1996-2003).

Authors:
Rowan J Milner
Rowan J Milner
University of Florida
United States
Jamie Peyton
Jamie Peyton
University of California Davis
Kirsten Cooke
Kirsten Cooke
College of Veterinary Medicine
United States
Leslie E Fox
Leslie E Fox
College of Veterinary Medicine
United States
Alexander Gallagher
Alexander Gallagher
Virginia-Maryland Regional College of Veterinary Medicine
United States
Patti Gordon
Patti Gordon
University of Florida
United States

J Am Vet Med Assoc 2005 Oct;227(7):1118-22

Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610-0126, USA.

Objective: To determine response rates and survival times for cats with lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol.

Design: Retrospective study.

Animals: 38 cats with lymphoma.

Procedure: Medical records were reviewed, and information on age, sex, breed, FeLV and FIV infection status, anatomic form, clinical stage, and survival time was obtained. Immunophenotyping was not performed.

Results: Mean +/- SD age of the cats was 10.9 +/- 4.4 years. Overall median survival time was 210 days (interquartile range, 90 to 657 days), and overall duration of first remission was 156 days (interquartile range, 87 to 316 days). Age, sex, anatomic form, and clinical stage were not significantly associated with duration of first remission or survival time. Eighteen of the 38 (47%) cats had complete remission, 14 (37%) had partial remission, and 6 (16%) had no response. Duration of first remission was significantly longer for cats with complete remission (654 days) than for cats with partial remission (114 days). Median survival time for cats with complete remission (654 days) was significantly longer than median survival time for cats with partial remission (122 days) and for cats with no response (11 days).

Conclusions And Clinical Relevance: Results suggested that a high percentage of cats with lymphoma will respond to treatment with the University of Wisconsin-Madison chemotherapy protocol. Age, sex, anatomic form, and clinical stage were not significantly associated with duration of first response or survival time, but initial response to treatment was.
October 2005
10 Reads

Publication Analysis

Top Keywords

survival time
24
university wisconsin-madison
12
form clinical
12
wisconsin-madison chemotherapy
12
cats complete
12
age sex
12
partial remission
12
complete remission
12
clinical stage
12
anatomic form
12
cats lymphoma
12
median survival
12
duration remission
12
cats
11
remission
9
time cats
8
remission 654
8
days cats
8
cats partial
8
days
8

Similar Publications

Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997)

J Am Vet Med Assoc 1998 Oct;213(8):1144-9

Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis 95616-8734, USA.

Objective: To determine clinical and pathologic findings in cats with alimentary malignant lymphoma and results of treatment with a combination of prednisone, L-asparaginase, vincristine, cyclophosphamide, doxorubicin, and methotrexate.

Design: Retrospective study.

Animals: 21 cats with alimentary malignant lymphoma. Read More

View Article
October 1998

Alimentary lymphoma in cats: 28 cases (1988-1993).

J Am Vet Med Assoc 1995 Dec;207(12):1593-8

Department of Medicine, School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.

Objective: To evaluate response to chemotherapy in cats with alimentary lymphoma and to determine factors associated with survival time.

Design: Retrospective case series.

Animals: 28 cats with alimentary lymphoma that underwent chemotherapy. Read More

View Article
December 1995

Therapy for Australian cats with lymphosarcoma.

Aust Vet J 2001 Dec;79(12):808-17

Department of Veterinary Clinical Sciences, Faculty of Veterinary Science, The University of Sydney, New South Wales.

Objective: To determine the response of Australian cats with lymphosarcoma to chemotherapy and/or surgery in relation to patient and tumour characteristics, haematological and serum biochemical values and retroviral status.

Design: Prospective study of 61 client-owned cats with naturally-occurring lymphosarcoma subjected to multi-agent chemotherapy and/or surgery.

Procedure: An accepted chemotherapy protocol utilising l-asparaginase, vincristine, cyclophosphamide, doxorubicin, methotrexate and prednisolone was modified and used to treat 60 cats with lymphosarcoma. Read More

View Article
December 2001

Feline extranodal lymphoma: response to chemotherapy and survival in 110 cats.

J Small Anim Pract 2009 Nov;50(11):584-92

The Feline Centre, Department of Clinical Veterinary Science, Division of Companion Animals, University of Bristol, Langford, Bristol BS405DU.

Objective: To determine response to treatment, survival and prognostic factors for feline extranodal lymphoma in the UK.

Methods: Records of cats diagnosed with lymphoma of extranodal sites at seven referral centres were reviewed and information on signalment, tumour location, prior treatment and chemotherapy protocol recorded. Factors influencing response to treatment and survival were assessed. Read More

View Article
November 2009